Ralph Dutt-Ballerstadt

Summary

Affiliation: University of Texas M.D. Anderson Cancer Center
Country: USA

Publications

  1. ncbi request reprint Affinity-based turbidity sensor for glucose monitoring by optical coherence tomography: toward the development of an implantable sensor
    Ralph Ballerstadt
    BioTex, Inc, 8058 El Rio Street, Houston, Texas 77054, USA
    Anal Chem 79:6965-74. 2007
  2. pmc Acute in vivo performance evaluation of the fluorescence affinity sensor in the intravascular and interstitial space in Swine
    Ralph Dutt-Ballerstadt
    BioTex Inc, Houston, Texas 77054, USA
    J Diabetes Sci Technol 7:35-44. 2013
  3. pmc A human pilot study of the fluorescence affinity sensor for continuous glucose monitoring in diabetes
    Ralph Dutt-Ballerstadt
    BioTex Inc, Houston, Texas 77054, USA
    J Diabetes Sci Technol 6:362-70. 2012
  4. ncbi request reprint Fluorescence resonance energy transfer-based near-infrared fluorescence sensor for glucose monitoring
    Ralph Ballerstadt
    BioTex, Inc, Houston, Texas 77054, USA
    Diabetes Technol Ther 6:191-200. 2004
  5. ncbi request reprint Concanavalin A for in vivo glucose sensing: a biotoxicity review
    Ralph Ballerstadt
    BioTex Inc, 8058 El Rio Street, Houston, TX 77054, USA
    Biosens Bioelectron 22:275-84. 2006
  6. ncbi request reprint In vivo performance evaluation of a transdermal near- infrared fluorescence resonance energy transfer affinity sensor for continuous glucose monitoring
    Ralph Ballerstadt
    BioTex, Inc, Houston, Texas 77054, USA
    Diabetes Technol Ther 8:296-311. 2006
  7. pmc Preclinical in vivo study of a fluorescence affinity sensor for short-term continuous glucose monitoring in a small and large animal model
    Ralph Dutt-Ballerstadt
    BioTex, Inc, Houston, TX 77054, USA
    Diabetes Technol Ther 10:453-60. 2008
  8. ncbi request reprint In vitro long-term performance study of a near-infrared fluorescence affinity sensor for glucose monitoring
    Ralph Ballerstadt
    BioTex Inc, 8018 El Rio, Houston, TX 77054, USA
    Biosens Bioelectron 19:905-14. 2004
  9. ncbi request reprint A label-free fiber-optic Turbidity Affinity Sensor (TAS) for continuous glucose monitoring
    Ralph Dutt-Ballerstadt
    BioTex, Inc, 8058 El Rio Street, Houston, TX 77054, USA Electronic address
    Biosens Bioelectron 61:280-4. 2014

Research Grants

Collaborators

Detail Information

Publications9

  1. ncbi request reprint Affinity-based turbidity sensor for glucose monitoring by optical coherence tomography: toward the development of an implantable sensor
    Ralph Ballerstadt
    BioTex, Inc, 8058 El Rio Street, Houston, Texas 77054, USA
    Anal Chem 79:6965-74. 2007
    ....
  2. pmc Acute in vivo performance evaluation of the fluorescence affinity sensor in the intravascular and interstitial space in Swine
    Ralph Dutt-Ballerstadt
    BioTex Inc, Houston, Texas 77054, USA
    J Diabetes Sci Technol 7:35-44. 2013
    ..Research Design and..
  3. pmc A human pilot study of the fluorescence affinity sensor for continuous glucose monitoring in diabetes
    Ralph Dutt-Ballerstadt
    BioTex Inc, Houston, Texas 77054, USA
    J Diabetes Sci Technol 6:362-70. 2012
    ..The device was assessed based on performance, safety, and comfort level under acute conditions (4 h)...
  4. ncbi request reprint Fluorescence resonance energy transfer-based near-infrared fluorescence sensor for glucose monitoring
    Ralph Ballerstadt
    BioTex, Inc, Houston, Texas 77054, USA
    Diabetes Technol Ther 6:191-200. 2004
    ..Its small size, ratiometric output, and NIR fluorescence make this sensor well suited for dermal implantation and continuous transdermal monitoring...
  5. ncbi request reprint Concanavalin A for in vivo glucose sensing: a biotoxicity review
    Ralph Ballerstadt
    BioTex Inc, 8058 El Rio Street, Houston, TX 77054, USA
    Biosens Bioelectron 22:275-84. 2006
    ....
  6. ncbi request reprint In vivo performance evaluation of a transdermal near- infrared fluorescence resonance energy transfer affinity sensor for continuous glucose monitoring
    Ralph Ballerstadt
    BioTex, Inc, Houston, Texas 77054, USA
    Diabetes Technol Ther 8:296-311. 2006
    ..This study clearly demonstrates the feasibility of the proposed transdermal FRET-based sensor interrogation concept for glucose monitoring...
  7. pmc Preclinical in vivo study of a fluorescence affinity sensor for short-term continuous glucose monitoring in a small and large animal model
    Ralph Dutt-Ballerstadt
    BioTex, Inc, Houston, TX 77054, USA
    Diabetes Technol Ther 10:453-60. 2008
    ..The performance of a fiber-coupled fluorescence affinity sensor (FAS) was studied in vivo in small and large animal models, in order to assess its feasibility and safety for short-term glucose monitoring in humans...
  8. ncbi request reprint In vitro long-term performance study of a near-infrared fluorescence affinity sensor for glucose monitoring
    Ralph Ballerstadt
    BioTex Inc, 8018 El Rio, Houston, TX 77054, USA
    Biosens Bioelectron 19:905-14. 2004
    ..Extrapolation of the experimental data suggests that a leak-proof sensor would be remarkably stable with a fluorescence decrease of only 15% over a 1-year period...
  9. ncbi request reprint A label-free fiber-optic Turbidity Affinity Sensor (TAS) for continuous glucose monitoring
    Ralph Dutt-Ballerstadt
    BioTex, Inc, 8058 El Rio Street, Houston, TX 77054, USA Electronic address
    Biosens Bioelectron 61:280-4. 2014
    ....

Research Grants4

  1. Nanoparticle-Based Optical Sensor for Glucose Monitoring
    Ralph Ballerstadt; Fiscal Year: 2006
    ..abstract_text> ..
  2. 5-Day Fiber-Coupled Sensor Interstitial Glucose
    Ralph Ballerstadt; Fiscal Year: 2006
    ..We believe the proposed sensor can provide a solution for short-term (3-5 days) continuous monitoring that will be accurate, reliable, and convenient for patient use. ..
  3. Fluorescence Sensor Probe for Transcutaneous Glucose Sensing
    Ralph Ballerstadt; Fiscal Year: 2007
    ..The overall result will be a healthier life for people with diabetes and lower medical costs for diabetes care for the society. ..